COVID-19 RESURGENCE | J&K set to receive ‘iNCOVACC’ booster dose by January 2023 end

0
348

Srinagar, Dec 31: Amid COVID-19 resurgence, Jammu and Kashmir is going to receive Bharat Biotech’s intranasal COVID vaccine ‘iNCOVACC’ for booster dose by January 2023 end. iNCOVACC, the COVID nasal vaccine, is non-invasive, needle-free and easy to administer as it does not require trained healthcare workers.Director General of Health and Family Welfare (H&FW), Dr Saleem-ur-Rehman told Greater Kashmir that COVID nasal spray would be available from January 2023. “The nasal spray iNCOVACC will be available at private markets. The precaution doses will also be available soon in Kashmir,” he said.Officials of the Health Department told Greater Kashmir that till now, they had not received any guidelines from the centre regarding iNCOVACC.The world’s first intra-nasal vaccine for COVID developed by India is expected to give India the much-needed boost as the country prepares itself to tackle a possible COVID surge.iNCOVACC is priced at Rs 800 (excluding GST) at private markets and Rs 325 (excluding GST) for government supplies.J&K government has also projected a demand to the Ministry of Health and Family Welfare (MoHFW) for precaution dose especially for 60 plus and people with comorbidities.